Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Healios KK Ord Shs HLOSF

HEALIOS K.K. is a Japan-based company mainly engaged in research and development of pharmaceutical products. The Company has compound pharmaceutical products line and induced pluripotent stem cell (iPSC) regenerative medicine product line. The compound pharmaceutical product line contains HLM0021, HLM0022 and HLM0023. The products are ophthalmological surgery adjuvants, mainly contain brilliant blue G-250 (BBG250) which help capsule temporarily safely stained to protect the inner limiting membranes and lens during surgery of vitreous and cataract. The iPSC regenerative medicine product line contains HLCR011 and HLCR012. The products are in the preclinical testing and preparation for trial in Japan, which are candidate of regenerative medicine products. The products are iPS cell derived retinal pigment epithelium (RPE) cell suspension and sheet developed in Japan, United States and Europe.


PINL:HLOSF - Post by User

Post by The300on Jul 15, 2011 4:13pm
251 Views
Post# 18837162

Depth

DepthDepth is looking a little better lately.  Bids are stacking up and getting slightly higher.

# Orders Shares Bid Ask Shares # Orders
1 10000 0.195 0.220 14500 1
2 11000 0.190 0.235 15000 1
5 51500 0.185 0.240 8000 1
2 6500 0.180 0.250 15000 3
2 18000 0.175 0.270 17000 1

At $.20, Halo has a market cap of approx. $6,000,000.

Take into account that on Feb. 28, 2011 the company had $2.8 million on hand i believe, and an additional $1.2 million from the sale of the NSR, the company should have roughly between $3-$4 million in cash, assuming they didn't burn through it in the past few months for some unknown reason.

In essence, all of Sherridon, JV area, and other properties are being given a market cap of $2-3 million when you take into account the money in the coffers.

Seems like good value, but then again, I thought there was good value at $.50.

We haven't heard anything on the cold-lost production with Hudbay.  I thought we would have heard something by now, which makes me believe that maybe they won't be taking it into production after all.  Either way an update would be nice.

Lets see if management can surprise us.

As always, IMHO

The 300
<< Previous
Bullboard Posts
Next >>